By the time this issue reaches your hands, most everyone in the clinical lab industry will be setting their sights on Anaheim and this year’s American Association of Clinical Chemistry meeting and Clinical Lab Expo. The team at CLP looks forward to this event, where we have an opportunity to connect with readers and vendors, and to keep on top of trends and new developments in the clinical lab marketplace. If you haven’t yet reached out to us, please feel free to do so, and hopefully, we can arrange a time to meet during the show.
Looking through the AACC program, it appears that the topics of personalized and preventative medicine remain hot issues in the clinical lab space. Four of the five plenary sessions feature biomarkers and/or personalized medicine approaches to diagnostics, pointing to a new paradigm for medicine that is proactive rather than reactive. This theme is repeated in the 1-day workshops, which include sessions on nucleic acid testing, tumor markers, and point-of-care diagnostics.
Look to CLP for continued coverage of the technologies that will allow your lab to stay up to speed during this transition—namely, PCR and other molecular testing, genome sequencing, and mass spectrometry. Of course, the mainstays of the clinical lab will continue to be featured, such as this month’s survey and overview of chemistry analyzers, as well as our feature on lab safety products, always a popular and important topic among laboratorians.
Again, I invite you to reach out to the CLP team prior to or during the AACC meeting. CLP‘s associate editor, Stephen Noonoo, and myself will be assiduously making the rounds of as many booths as we can possibly fit in, and we look forward to hearing from you. E-mail us at or . We hope to see you!
To follow CLP‘s editors at AACC, visit our blog.
Best regards,
Suzanne Clancy, PhD
editor, CLP
; (858) 793-9533
